|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.660 AUD | +4.72% |
|
-1.12% | -14.19% |
| Capitalization | 3.41B 2.26B 1.95B 1.82B 1.7B 3.13B 204B 21.28B 8.23B 96.44B 8.5B 8.32B 352B | P/E ratio 2026 * |
-155x | P/E ratio 2027 * | 28.6x |
|---|---|---|---|---|---|
| Enterprise value | 3.36B 2.23B 1.92B 1.79B 1.67B 3.08B 201B 20.97B 8.12B 95.05B 8.38B 8.2B 347B | EV / Sales 2026 * |
22.8x | EV / Sales 2027 * | 9.15x |
| Free-Float |
74.47% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Mesoblast Limited
| 1 day | +4.72% | ||
| 1 week | -1.12% | ||
| Current month | -1.85% | ||
| 1 month | +10.37% | ||
| 3 months | +33.67% | ||
| 6 months | +52.87% | ||
| Current year | -14.19% |
| 1 week | 2.5 |  | 2.7 |
| 1 month | 2.2 | | 2.76 |
| Current year | 1.52 | | 3.37 |
| 1 year | 1.52 | | 3.37 |
| 3 years | 0.26 | | 3.37 |
| 5 years | 0.26 | | 4.72 |
| 10 years | 0.26 | | 5.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Silviu Itescu
CEO | Chief Executive Officer | 68 | 22/03/2011 |
James O'Brien
DFI | Director of Finance/CFO | 58 | 16/11/2025 |
Eric Rose
CTO | Chief Tech/Sci/R&D Officer | 74 | 31/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Eric Rose
BRD | Director/Board Member | 74 | 14/04/2013 |
William Burns
BRD | Director/Board Member | 78 | 05/03/2014 |
Philip Facchina
BRD | Director/Board Member | 63 | 28/03/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.72% | -1.12% | +51.14% | +140.72% | 2.16B | |
| -0.95% | -0.66% | +2.80% | +7.78% | 48.03B | |
| +0.41% | -2.57% | +11.16% | +3.73% | 38.3B | |
| -2.56% | -5.21% | +62.19% | +59.96% | 36.67B | |
| +0.38% | -1.03% | +9.38% | +19.64% | 27.13B | |
| +0.61% | -9.64% | +58.27% | +162.26% | 15.35B | |
| +1.48% | +2.66% | +65.06% | +211.95% | 15.17B | |
| +0.05% | +1.21% | -13.35% | -12.77% | 14.19B | |
| +0.43% | -0.71% | +32.20% | - | 13.58B | |
| -0.16% | -1.23% | +119.87% | +102.58% | 13.25B | |
| Average | +0.41% | -2.24% | +39.87% | +77.32% | 22.38B | |
| Weighted average by Cap. | -0.32% | -1.79% | +30.94% | +49.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 147M 97.73M 83.96M 78.58M 73.27M 135M 8.79B 918M 355M 4.16B 367M 359M 15.19B | 349M 232M 199M 186M 174M 320M 20.82B 2.18B 842M 9.86B 869M 851M 36B |
| Net income | -46.85M -31.09M -26.71M -25M -23.31M -42.93M -2.8B -292M -113M -1.32B -117M -114M -4.83B | 78.43M 52.06M 44.72M 41.86M 39.03M 71.88M 4.68B 489M 189M 2.22B 195M 191M 8.09B |
| Net Debt | -49.34M -32.75M -28.13M -26.33M -24.55M -45.21M -2.94B -308M -119M -1.39B -123M -120M -5.09B | -218M -144M -124M -116M -108M -199M -12.99B -1.36B -525M -6.15B -542M -531M -22.45B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/12/25 | 2.660 $ | +4.72% | 3,575,298 |
| 04/12/25 | 2.540 $ | +0.79% | 3,976,219 |
| 03/12/25 | 2.520 $ | -2.33% | 2,505,455 |
| 02/12/25 | 2.580 $ | -3.37% | 3,338,222 |
| 01/12/25 | 2.670 $ | -1.48% | 3,382,575 |
Delayed Quote Australian S.E., December 05, 2025 at 05:10 am
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MSB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition